Process View
Any process that modulates the activity of a monooxygenase.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of monooxygenase activity"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| ESR1 | estrogen receptor 1 | 0.418 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.408 | ||
| MAPT | microtubule-associated protein tau | 0.395 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.337 | Human | |
| IL1R1 | interleukin 1 receptor, type I | 0.332 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.310 | Human | |
| MPDZ | multiple PDZ domain protein | 0.235 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.230 | ||
| REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.182 | Human | |
| PARD6A | par-6 partitioning defective 6 homolog alpha (C. elegans) | 0.179 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.146 | ||
| MAGI2 | membrane associated guanylate kinase, WW and PDZ domain containing 2 | 0.128 | ||
| EGFR | epidermal growth factor receptor | 0.127 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.123 | ||
| IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.106 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.089 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.083 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.075 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.073 | ||
| HP | haptoglobin | 0.073 | ||
| NFKBIB | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta | 0.073 | ||
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.072 | ||
| NOXA1 | NADPH oxidase activator 1 | 0.060 | ||
| IL1RAP | interleukin 1 receptor accessory protein | 0.058 | ||
| IL1B | interleukin 1, beta | 0.056 | ||
| DSG2 | desmoglein 2 | 0.054 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.054 | ||
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.052 | Human | |
| DLG2 | discs, large homolog 2 (Drosophila) | 0.051 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.051 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.042 | ||
| TNIP2 | TNFAIP3 interacting protein 2 | 0.038 | ||
| CDCP1 | CUB domain containing protein 1 | 0.038 | ||
| HR | hairless homolog (mouse) | 0.038 | ||
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.037 | ||
| APOC1 | apolipoprotein C-I | 0.037 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.036 | Human | |
| PARD6G | par-6 partitioning defective 6 homolog gamma (C. elegans) | 0.036 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.034 | ||
| PRKCD | protein kinase C, delta | 0.031 | Human | |
| ANKS1B | ankyrin repeat and sterile alpha motif domain containing 1B | 0.031 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.029 | ||
| MYLK2 | myosin light chain kinase 2 | 0.029 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.029 | ||
| CALCA | calcitonin-related polypeptide alpha | 0.028 | ||
| CAV2 | caveolin 2 | 0.028 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.026 | Human | |
| APOC3 | apolipoprotein C-III | 0.026 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.026 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.026 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.026 | Human | |
| BTRC | beta-transducin repeat containing | 0.025 | ||
| CHUK | conserved helix-loop-helix ubiquitous kinase | 0.024 | ||
| MATK | megakaryocyte-associated tyrosine kinase | 0.022 | ||
| CEACAM1 | carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | 0.021 | ||
| BAZ1A | bromodomain adjacent to zinc finger domain, 1A | 0.021 | ||
| ERBB4 | v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) | 0.021 | Human | |
| PRKCB | protein kinase C, beta | 0.021 | ||
| APP | amyloid beta (A4) precursor protein | 0.020 | ||
| LCAT | lecithin-cholesterol acyltransferase | 0.020 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.020 | ||
| IL8 | interleukin 8 | 0.020 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.019 | ||
| PRKCA | protein kinase C, alpha | 0.019 | ||
| PLEKHA1 | pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1 | 0.019 | ||
| CD83 | CD83 molecule | 0.018 | ||
| MUC1 | mucin 1, cell surface associated | 0.018 | ||
| ITGAM | integrin, alpha M (complement component 3 receptor 3 subunit) | 0.017 | ||
| SH3RF1 | SH3 domain containing ring finger 1 | 0.017 | ||
| JUP | junction plakoglobin | 0.016 | ||
| PRKCZ | protein kinase C, zeta | 0.016 | Human | |
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.015 | ||
| PTPRA | protein tyrosine phosphatase, receptor type, A | 0.015 | ||
| NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.015 | ||
| ARRDC3 | arrestin domain containing 3 | 0.014 | ||
| DSP | desmoplakin | 0.014 | ||
| PKP3 | plakophilin 3 | 0.014 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.014 | ||
| OSBPL8 | oxysterol binding protein-like 8 | 0.014 | ||
| IL1A | interleukin 1, alpha | 0.014 | Human | |
| PTPRF | protein tyrosine phosphatase, receptor type, F | 0.014 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.014 | ||
| FRS2 | fibroblast growth factor receptor substrate 2 | 0.014 | ||
| TXNDC2 | thioredoxin domain containing 2 (spermatozoa) | 0.013 | ||
| NRG1 | neuregulin 1 | 0.013 | ||
| TGFA | transforming growth factor, alpha | 0.013 | ||
| APOA1 | apolipoprotein A-I | 0.013 | Human | |
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.013 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.013 | ||
| SNCAIP | synuclein, alpha interacting protein | 0.013 | ||
| A2M | alpha-2-macroglobulin | 0.013 | ||
| FABP4 | fatty acid binding protein 4, adipocyte | 0.013 | ||
| ADAM15 | ADAM metallopeptidase domain 15 | 0.013 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.013 | ||
| TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | 0.012 | ||
| PTEN | phosphatase and tensin homolog | 0.012 | ||
| APC | adenomatous polyposis coli | 0.012 | ||
| CLEC4E | C-type lectin domain family 4, member E | 0.012 | Human | |
| OR2AG1 | olfactory receptor, family 2, subfamily AG, member 1 | 0.012 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.011 | ||
| TRIM9 | tripartite motif containing 9 | 0.011 | ||
| F2R | coagulation factor II (thrombin) receptor | 0.011 | ||
| SSTR3 | somatostatin receptor 3 | 0.011 | ||
| STAT5A | signal transducer and activator of transcription 5A | 0.011 | ||
| PKLR | pyruvate kinase, liver and RBC | 0.011 | ||
| TRO | trophinin | 0.011 | ||
| BAG1 | BCL2-associated athanogene | 0.010 | ||
| CYBA | cytochrome b-245, alpha polypeptide | 0.010 | ||
| TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.010 | ||
| AR | androgen receptor | 0.010 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.010 | ||
| DLG3 | discs, large homolog 3 (Drosophila) | 0.010 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.010 | ||
| PDCD6IP | programmed cell death 6 interacting protein | 0.010 |